The top 7 AUCs >0.9 (AURKA, PLK1, PLAU, MMP14, HSP90B1, SERPINE1, and CDK4) are visualized in Figure 5F, indicating they may be promising targets for anti-HNSCC therapy. Here, PLAU is linked to head and neck squamous cell carcinoma.